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Background: Thrombus formed in blood vessels lead to atherothrombotic diseases such as myocardial or cerebral
infarction. Thrombolytic agents are used to dissolve the already formed clots in the blood vessels; however, these
drugs sometimes cause serious and fatal consequences. Herbal preparations have been used since ancient times for
the treatment of several diseases although they show little toxicity in some cases. Aqueous extracts of herbs used
in thrombolysis have been reported before with cytotoxic data, however, the organic extracts of herbs have not
been documented. This study aims to investigate whether organic extracts possess thrombolytic properties with
minimal or no toxicity.
Methods: An in vitro thrombolytic model was used to check the clot lysis effect of six Bangladeshi herbal extracts
viz., Ageratum conyzoides L., Clausena suffruticosa, Leea indica (Burm.f.) Merr., Leucas aspera Willd., Senna sophera L.
Roxb., and Solanum torvum Swartz. using streptokinase as a positive control and water as a negative control. Briefly,
venous blood drawn from twenty healthy volunteers was allowed to form clots which were weighed and treated
with the test plant materials to disrupt the clots. Weight of clot after and before treatment provided a percentage
of clot lysis. Cytotoxicity was screened by brine shrimp lethality bioassay using vincristine sulfate as positive control.
Results: Using an in vitro thrombolytic model, Ageratum conyzoides, Clausena suffruticosa, Leea indica,
Leucas aspera, Senna sophera and Solanum torvum showed 18.12 ± 2.34%, 48.9 ± 2.44%, 39.30 ± 0.96%,
37.32 ± 2.00%, 31.61 ± 2.97% and 31.51 ± 0.57% and clot lysis respectively. Among the herbs studied Clausena
suffruticosa, Leea indica and Leucas aspera showed very significant (p < 0.0001) percentage (%) of clot lysis
compared to reference drug streptokinase (75.00 ± 3.04%). In brine shrimp cytotoxic assay, the extracts Ageratum
conyzoides, Clausena suffruticosa, Leea indica, Leucas aspera, Senna sophera and Solanum torvum showed LC50 values
508.86 ± 6.62,41.16 ± 1.26, 2.65 ± 0.16, 181.67 ± 1.65, 233.37 ± 7.74 and 478.40 ± 3.23 μg/ml, respectively, with
reference to vincristine sulfate (LC50 0.76 ± 0.04).
Conclusion: Through our study it was found that Clausena suffruticosa, Leea indica and Leucas aspera possessed
effective thrombolytic properties whereas Senna sophera and Solanum torvum showed moderate to mild
thrombolytic effects while Ageratum conyzoides showed no significant effect. No extract was found cytoxic
compared to positive control. Clausena suffruticosa, Leea indica and Leucas aspera could be incorporated as a
thrombolytic agent with in vivo effects to improve the atherothrombotic patients. However, Clausena suffruticosa
could be the best one to use in this purpose.
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Coronary artery thrombosis has been treated by urokin-
ase (UK), streptokinase (SK) or tissue plasminogen acti-
vators (t-PA) which are widely used clinical thrombolytic
agent for the treatment of severe or massive deep venous
thrombosis, pulmonary embolism, myocardial infarction,
and occluded intravenous or dialysis cannulas [1]. Al-
though UK and SK are widely used in India, Bangladesh
and other developing countries due to lower cost [2] as
compared to other thrombolytic drugs but, the use is
associated with high risk of bleeding intracranial he-
morrhage, severe anaphylactic reaction and lacks specifi-
city [3]. Moreover, these drugs are not used in patients
who have undergone surgery or those with a history of
nervous lesions, gastrointestinal bleeding or hyperten-
sion [3]. However, as a result of immunogenicity mul-
tiple treatments with SK in a given patient are restricted
[4]. Thrombolytic therapy with recombinant t-PA is
effective in acute myocardial infarction, but the treat-
ment is limited by a fairly slow reperfusion rate and
frequent early reocclusions. Moreover, the platelet-rich
thrombi are highly resistant to lysis by t-PA [5]. Another
thrombolytic agent fucoidan, a branched sulfated fucan
extracted from brown seaweeds with anticoagulant and
antithrombotic effects mediated by direct thrombin
inhibition has been reported recently [1].
However, herbal drugs are wide-spoken as green medi-
cine for their safe and dependable health care paradigms.
The traditional herbal medicines increased an uprising
interest since couple of decades due to their incredible
pharmacological activities, economic viability and less
side effects in different healthcare management system
[6]. Thus, tremendous efforts have also been directed
towards the discovery and development of natural pro-
ducts with antiplatelet [7,8], anticoagulant [9,10], antith-
rombotic [11] and thrombolytic activity of the plants not
documented. Epidemiologic studies have provided evi-
dence that foods with experimentally proved antithrom-
botic effect could reduce risk of thrombosis. Some
plants or plant parts showing thrombolytic activity have
also been reported [12,13]. Ageratum conyzoides L. (Goat
weed or white weed or Chuva), Clausena suffruticosa
(Kalomoricha), Leea indica (Burm.f.) Merr. (Achilagach
or Arengi), Leucas aspera Willd. (Darkolos or Dandokolos),
Senna sophera L. Roxb. (Kanduak or Khuksu), and Sola-
num torvum Swartz. (Titbegun) are native to Bangladesh.
They are used as traditional medicines for cardiac diseases
and blood purification. Recently, A. conyzoides was re-
ported to have hematological and lymphocyte increasing
activity [14]. Roots, leaves and seeds of C. suffruticosa are
used in the treatment of bleeding and cerebrospinal menin-
gitis [15,16]. Flowers, roots and leaves of L. indica are used
as anti-inflammatory, anxiolytic and cardioprotective
[17-19]. Leucas aspera stem and whole plant were found topossess anti-inflammatory and blood purifying effects
[20,21]. Solanum torvum aqueous extract is reported to
contribute in increasing red blood cells and hemoglobin
concentration above baseline values within 24 days [22].
But their thrombolytic effects and usability in context of
toxicity have not been studied at all.
This study aims to investigate the ethanol extracts of
the aforementioned six Bangladeshi medicinal plants
viz., Ageratum conyzoides (A. conyzoides), Clausena suf-
fruticosa (C. suffruticosa), Leea indica (L. indica), Leucas
aspera (L. aspera), Senna sophera (S. sophera) and Sola-
num torvum (S. torvum) for their clot lysis (thrombolytic
activity) and cytotoxic properties by using in vitro models.
Methods
Plant collection and identification
Whole plants of A. conyzoides (Accession No. 36073),
root of C. suffruticosa (Accession No. 32909), leaf
of L. indica (Accession No. 36078), whole plants of
L. aspera (Accession No. 36070), leaf of S. sophera
(Accession No. 36072) and fruits of S. torvum (Acces-
sion No. 36071) were collected from different parts of
Chittagong region, Bangladesh. The plants were identi-
fied by Dr. Shaikh Bokhtear Uddin, Taxonomist and
Associate Professor, Department of Botany, University of
Chittagong. The sample specimens of the identified
plants have been preserved in the national herbarium
with the mentioned accession numbers.
Chemicals and reagents
To the commercially available lyophilized Streptokinase
(SK) vial (Durakinase, Dongkook Phama. Co. Ltd, South
Korea) of 15 00000 I.U., 5 ml sterile distilled water was
added and mixed properly. This suspension was used as
a stock from which 100 μl (30,000 I.U) was used for
in vitro thrombolysis. Absolute ethanol (99.50%) and
vincristine sulfate (VS) were purchased from Sigma-
Aldrich, Munich, Germany.
Extract preparation
Each of the plant materials was dried and ground
(Moulinex Blender AK-241, Moulinex, France) into pow-
der (40-80mesh, 500 g) and soaked for 7 days with 2–3
days interval in 2.0 L of ethanol at room temperature
(23 ± 0.5°C). Filtrate obtained through cheesecloth and
Whatman filter paper No. 1 was concentrated under
reduced pressure at the temperature below 50°C using
rotary evaporator (RE 200, Sterling, UK). The extracts
(yield 4.4–5.6% W/W) were all placed in glass Petri
dishes (90 X 15 mm, Pyrex, Germany). A 100 mg each
of the extracts was suspended in 10 ml distilled water
and the suspension was shaken vigorously on a vortex
mixer. The suspension was kept overnight and decanted
to remove the soluble supernatant, which was filtered
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ous preparation was added to the microcentrifuge tubes
containing the clots to check thrombolytic activity. The
same concentration (10 mg/ml) of extracts was prepared
for screening the cytotoxic properties.
Blood specimen
Whole blood (4 ml) was drawn from healthy human
volunteers (n = 20) without a history of oral contracep-
tive or anticoagulant therapy using a protocol approved
by the Institutional Ethics Committee of Chittagong
University, faculty of medicine. An earlier consent, ap-
proval number HET-CU2011/1, was taken from the fac-
ulty of medicine, University of Chittagong, for collection
of blood samples from Human volunteers. Blood collec-
tion and preservation were conducted by Dr. M Rafiqur
Rahman (Pathologist, faculty of Medicine, University of
Chittagong). A 500 μl of blood was transferred to each
of the eight previously weighed microcentrifuge tubes to
form clots.
Statement on informed consent of the donors
The volunteer donors were supplied a consent form
which informed the title of the research project, name
and detail contact of investigators as well as purpose of
the research. Description of the research mentioning
step-by-step brief of the proposed research, inclusion
and exclusion criteria of the donors, whether donors will
receive any therapy or not, volume of blood to be taken,
possible discomfort of the puncture sites, time required
for the blood sampling. Explanation was made on if
future use of the research data beyond the current study
is anticipated, whether this is a focus group if so the
Principal Investigator should put a procedure in place in
which the researchers caution people about the limit on
confidentiality. Access to Research Information regard-
ing who would have access to the collected sample,
information regarding retention of sample and schedules
for their disposal were also detailed. It was indicated to
the consent form that the volunteers might refuse to
donate blood at any time. Donor whether could with-
draw his sample data was disclosed. The sample was
restricted for that individual study not for future re-
search projects was presented in the consent form.
Potential harm, injuries, discomforts or inconvenience
associated with donors in this study was added as
informed consent statement. If there was known harm
to the donors, the potential harm, current knowledge
regarding the probability of the occurrence of the harm,
clinical importance of the harm; and any relevant know-
ledge regarding the probability of reversibility; for ex-
ample the possibility of bruising or swelling while giving
blood, or some other discomforts at the site where blood
is drawn and that there might be minimal chance ofinfection, and that these discomforts were brief and
transient were also added. Potential benefits of the
donors, not directly, but the society in general or indivi-
duals with a similar condition might benefit from the
results of this study was explained. Treatment alternative
and possibility of the research was described. Confidenti-
ality statement was included in the consent form in the
way that “confidentiality will be respected and no infor-
mation that discloses the identity of the participant will
be released or published without consent unless required
by law of states. The legal obligation includes a number
of circumstances, such as suspected child abuse and
infectious disease, expression of suicidal ideas where
research documents are ordered to be produced by a
court of law and where researchers are obliged to report
to the appropriate authorities. In those rare instances
where it will not be possible to assure complete confi-
dentiality”, the limits on this obligation were carefully
explained. Reimbursement issue was also mentioned
whether the donors or their parents may be offered
money for reasonable out-of-pocket expenses for ex-
ample, transportation costs, meals, etc. Finally detail
contact (Name, area code and phone number) of investi-
gators was provided in case of any questions of the
donors about this study. The consent form was con-
cluded with major questions on above disclosures in
Yes/NO form followed by the signature (with date) of
the donor.Clot lysis
Experiments for clot lysis were carried as reported earlier
[23]. Briefly, four ml venous blood drawn from the healthy
volunteers was distributed in eight different pre weighed
sterile microcentrifuge tube (0.5 ml/tube) and incubated
at 37°C for 45 min. After clot formation, serum was com-
pletely removed without disturbing the clot and each tube
having clot was again weighed to determine the clot
weight (clot weight = weight of clot containing tube –
weight of tube alone). To each microcentrifuge tube
containing pre-weighed clot, 100 μl of organic extracts of
the six plants (A. conyzoides, C. suffruticosa, L. indica,
L. aspera, S. sophera and S. torvum) were added separ-
ately. As a positive control, 100 μl of SK and as a negative
non-thrombolytic control, 100 μl of distilled water
were separately added to the control tubes numbered.
All the tubes were then incubated at 37°C for 90 min
and observed for clot lysis. After incubation, fluid
released was removed and tubes were again weighed
to observe the difference in weight after clot disruption.
Difference obtained in weight taken before and after clot
lysis was expressed as percentage of clot lysis. The expe-
riment was repeated with the blood samples of the
20 volunteers.
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Figure 1 Clot lysis by streptokinase, water and various organic extracts. Effects of drugs on dissolution of clots prepared from blood of
normal individuals. Maximum clot lysis (75.00 ± 3.04%) was observed in clot treated with streptokinase (SK). Among herbal drugs C. suffruticosa
(Kalomoricha), L. indica (Achilagach) and L. aspera showed 48.90 ± 2.44%, 39.30 ± 0.96% and 37.32 ± 2.00% clot lysis, respectively. Water (as a
negative control) showed 4.19 ± 0.37% clot lysis. Data were processed with Tukey’s post hoc test for multiple comparisons, SPSS for windows,
version 18.0, p < 0.05) from each other.
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Brine shrimp bioassay was carried out with the method
as described by Meyer et al. (1982) [24] to investigate
the cytotoxicity of the extracts. The dried extract pre-
parations were re-dissolved in DMSO to obtain a solu-
tion of 10 mg/ml which was subjected to serial dilution
to get the concentrations between 20 μg/ml- 800 μg/ml.
A 5.0 ml of artificial sea water was added into all the test
tubes. Simple zoological organism (Artemia salina) was
used as a convenient monitor for cytotoxic screening.
The eggs of the brine shrimps were collected from the
Institute of Marine Science and Fisheries, University of
Chittagong, Bangladesh and hatched in artificial sea-
water (prepared by using sea salt 38 g/L and adjusted to
pH 8.5 using 1N NaOH) under constant aeration for 24
h under the light. The hatched shrimps were allowed to
grow by 48 h to get shrimp larvae called nauplii. After
48 h, active nauplii were attracted to one side in a glass
petri dish by using a micropipette. The nauplii were then
separated from the eggs by aliquoting them in another
glass petri dish containing artificial sea water and used
for the assay. Suspension containing 20 nauplii wasTable 1 Calculation of LC50 values, confidence limits, regressi
with reference to vincristine sulfate
Sample LC50 (μg/ml) Range of confidence l
VS 0.76 ± 0.04 0.57–0.82
A. conyzoides 508.86 ± 6.62 390.12–655.2
C. suffruticosa 41.16 ± 1.26 31.66–52.33
L. indica 2.65 ± 0.16 2.25–2.69
L. aspera 181.67 ± 1.65 125.12–265.9
S. sophera 233.37 ± 7.74 156.74–361.9
S. torvum 478.40 ± 3.23 345.78–611.0added into each test tube and was incubated at room
temperature (25±1°C) for 12 h under the light. The
tubes were then examined after 24 h and the number of
surviving larvae in each tube was counted with the aid
of a 3X magnifying glass. Experiments were conducted
along with VS in a set of three tubes per dose. The con-
centration that would kill 50% of the nauplii (LC50) was
determined from a linear regression equation using the
software “BioStat-2009”.
Statistical analysis
The significance between % clot lysis by SK and plant
extracts, LC50 values by VS and extracts was tested by the
paired t-test analysis using the software SPSS, version 19.0
(SPSS for Windows, Version 18.0, IBM Corporation,
New York, USA). Data are expressed as mean ± standard
deviation. The mean difference between positive and
negative control was considered significant at p < 0.05.
Results
Addition of 100 μl SK (positive control) to the clots along
with 90 min of incubation at 37°C, showed 75.00 ± 3.04%on equations and chi square values for different extracts
imit (μg/ml) Regression equation Chi square
Y= 3.16 + 2.98X 0.63
3 Y = − 2.16 + 2.65* X 0.70
Y = 2.92 + 4.03*X 1.58
Y = 45.98*X + S32 1.70
6 Y = 56.28X - 76.73 0.76
9 Y = 51.49X - 71.00 1.15
1 Y = 52.09* X - 79.45 0.93
Figure 2 Brine shrimp mortality by VS and different organic extracts. Percent mortality of brine shrimps of six plant extracts and standard
cytotoxic agent vincristine sulfate (VS). Data are shown as mean ± SD of twenty shrimps for each concentration. Mortality achieved by the
extracts of A. conyzoides, C. suffruticosa, L. indica, L. aspera, S. sophera and S. torvum are lower than that by VS. Data were processed with Tukey’s
post hoc test for multiple comparisons, SPSS for windows, version 18.0, p < 0.05) from each other.
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treated-clots showed only negligible clot lysis (4.19 ±
0.37%). The mean difference in clot lysis percentage be-
tween positive and negative control was very significant
(p value < 0.0001). Treatment of clots with A. conyzoides,





























Figure 3 Brine shrimp lethality by VS and different organic extracts. L
brine shrimp nauplii (Artemia salina). Data are shown as mean ± SD of twe
L. aspera, S. sophera and S. torvum showed LC50 values 508.86 ± 6.62, 41.16 ± 1.2
respectively, with reference to vincristine sulfate (LC50, 0.76 ± 0.04. Data were pr
windows, version 18.0, p < 0.05) from each other.S. torvum extracts provided the clot lysis 18.12 ± 2.34%,
48.90 ± 2.44%, 39.30 ± 0.96%, 37.32 ± 2.00%, 31.61 ±
2.97% and 31.51 ± 0.57%, respectively. The mean percent-
age of clot lysis by C. suffruticosa, L. indica and L. aspera
was statistically very significant (p value < 0.0001) com-
pared to those of both positive control SK and negative. indica L. aspera S. sophera S. torvum
ethal concentration (LC50) of VS and different organic extracts for
nty shrimps for each concentration. A. conyzoides, C. suffruticosa, L. indica,
6, 2.65 ± 0.16, 181.67 ± 1.65, 233.37 ± 7.74 and 478.40 ± 3.23 μg/ml,
ocessed with Tukey’s post hoc test for multiple comparisons, SPSS for
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tively lower percentage of clot lysis although the values
were significant (p value < 0.001) compared to those of
both positive control SK and negative control water. How-
ever, A. conyzoides did not show any significant clot lysis
effect. Percent clot lysis obtained after treating the clots
with different organic extracts and appropriate controls is
shown in Figure 1.
The regression analysis for brine shrimp bioassay was
presented in Table 1. Comparative mortality of brine
shrimps and LC50values for different extracts in reference
to control (VS) was shown in Figures 2 and 3, respectively.
No extract was found to be significantly toxic compared
to positive control. The L. indica extract had a smallest
LC50 value of 2.65 ± 0.16 μg/ml which was significantly
(p < 0.01) different from that (0.76 ± 0.04 μg/ml) of posi-
tive control indicating that the extract is not toxic
(Figure 2).
Discussion
Plant-derived medicines have a long history of use for
the prevention and treatment of human diseases. Today,
many pharmaceuticals currently approved by the Food
and Drug Administration (FDA) have origins to plant
sources. A major role for plant-derived compounds
based on the reported immunomodulatory effects has
emerged in recent times and has led to the rigorous
scientific examination to determine efficacy and safety
[25]. A number of plants source especially several fruits
and vegetables have been studied for their supplements
having anticoagulant, antiplatelet and fibrinolytic activity
and there is evidence that consuming such food leads to
prevention of coronary events and stroke [26-29]. Some
of these plant products are modified further with recom-
binant technology [30] to make them more effective and
site specific.
In our thrombolytic assay, the comparison of positive
control with negative control clearly demonstrated that
clot dissolution does not occur when water was added to
the clot. When compared with the clot lysis percentage
obtained through SK and water, an extremely significant
(p value < 0.0001) thrombolytic activity was observed
after treating the clots with C. suffruticosa, L. indica and
L. aspera extracts. However, the clot lysis values for
L. indica and L. aspera were lower than that of C. suffru-
ticosa. It is evidenced that there are bacterial contami-
nants of plants which have plasminogen receptors that
bind plasminogen. Cell surface bound plasminogen is
easily activated to plasmin, which could lead to fibrinoly-
sis [31]. Bacterial plasminogen activator: staphylokinase,
streptokinase, act as cofactor molecules that contribute
to exosite formation and enhance the substrate presenta-
tion to the enzyme. Staphylokinase activates plasmino-
gen to dissolve clots, also destroys the extracellularmatrix and fibrin fibers that hold cells together [32-34].
Interestingly the C. suffruticosa, L. indica and L. aspera
are known to have antibacterial activity which is con-
ducted against ten bacterial strains including E. coli and
Staphylococcus aureus [15,35,36]. Thus, the observed
thrombolytic effects could be linked to the antibacterial
activity of the plants. In context of the above, it would
be interesting to investigate the mechanism underlying
the clot lytic effects demonstrated by C. suffruticosa,
L. indica and L. aspera extract.
Toxicity of plant materials is a major concern to scien-
tists and medical practitioners [37-39] and therefore cyto-
toxic assay was conducted in this study to determine the
toxicity profile of the plant extracts through the Brine
Shrimp Lethality (LC50, 24 h) test. Lagarto [40] demon-
strated a good correlation (r = 0.85; P < 0.05) between the
LC50 of the brine shrimp lethality test and the acute oral
toxicity assay in mice. Based on that correlation, brine
shrimp lethality LC50 < 10 μg/ml (LD50 between 100 and
1000 mg/kg) is considered as the cutoff value of cytotox-
icity [6,40]. According to the measured LC50 values of the
extracts no one was found severely lethal or toxic to be
processed as pharmaceutical products in thrombolytic
uses. However, the extremely significant effect of C. suffru-
ticosa demonstrates it to be the best thrombolytic compo-
nent for further processing.
Conclusion
In conclusion, on the basis of beneficial effects of C. suf-
fruticosa, L. indica and L. aspera in the Bangladeshi trad-
itional medicine which was validated in this study, these
plant extracts possessed great blood clots lytic activity
in vitro; however, in vivo clot dissolving property and
active component(s) of C. suffruticosa for clot lysis are yet
to be investigated. Further work will establish whether or
not, phytochemicals derived from this plant could be
incorporated as a thrombolytic agent for the improvement
of the patients suffering from atherothrombotic diseases.
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